|
MNU+antimutagen(s)
dose ( m g/plate) |
S.typhimurium TA100 |
No of revertants |
±SD |
% of inhibition |
| 100+0 |
1643 |
166 |
|
| 10+0 |
392 |
26 |
|
| 100+0.3EA |
1624 |
164 |
-1 |
| 100+3EA |
1658 |
145 |
+1 |
| 100+30EA |
1567 |
166 |
-5 |
| 100+300EA |
1359 |
223 |
-17 |
| 100+0.3CRC |
1619 |
209 |
-2 |
| 100+3CRC |
1536 |
263 |
-7 |
| 100+30CRC |
1490 |
212 |
-9 |
| 100+300CRC |
1243 |
228 |
-24 |
| 100+0.3EA+0.3CRC |
1569 |
205 |
-5 |
| 100+3EA+3CRC |
1481 |
236 |
-10 |
| 100+30EA+30CRC |
1288* |
240 |
-22 |
| 100+300EA+300CRC |
1015** |
243 |
-38 |
| 10+0.3EA |
414 |
35 |
+6 |
| 10+3EA |
407 |
69 |
+4 |
| 10+30EA |
327 |
126 |
-17 |
| 10+300EA |
254** |
32 |
-35 |
| 10+0.3CRC |
385 |
47 |
-2 |
| 10+3CRC |
422 |
90 |
+8 |
| 10+30CRC |
211** |
21 |
-46 |
| 10+300CRC |
154** |
9 |
-61 |
| 10+0.3EA+0.3CRC |
406 |
89 |
+4 |
| 10+ 3EA+3CRC |
364 |
69 |
-7 |
| 10+30EA+30CRC |
187** |
29 |
-52 |
| 10+300EA+300CRC |
144** |
16 |
-63 |
| control-DMSO |
112 |
9 |
|
SD standard deviation
*Statistically significant difference between the sample with mutagen and
antimutagen(s) and the sample with specific mutagen p < 0.05
**Statistically significant difference between the sample with mutagen and
antimutagen(s) and the sample with specific mutagen p < 0.01
|
